Xeris Biopharma Holdings Inc

Xeris Biopharma Holdings Inc

XERS

Market Cap$632.69M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Xeris Biopharma Holdings IncXeris Biopharma Holdings Inc-11.2-213%4-1.8
$4.00

Target Price by Analysts

0.5% downsideXeris Biopharma Holdings Target Price DetailsTarget Price
$2.89

Current Fair Value

28.1% downside

Overvalued by 28.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$632.69 Million
Enterprise Value$615.51 Million
Dividend Yield$0 (0%)
Earnings per Share$-0.37
Beta0.89
Outstanding Shares149,092,881

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-11.17
PEG-38.38
Price to Sales4.02
Price to Book Ratio-4.02
Enterprise Value to Revenue3.31
Enterprise Value to EBIT-13.63
Enterprise Value to Net Income-10
Total Debt to Enterprise0.09
Debt to Equity-1.84

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Xeris Pharmaceuticals Inc

CEO: paul Edick